Home › Small Cell Lung Cancer › District of Columbia › Washington
Small Cell Lung Cancer clinical trials in Washington, DC
12 studies for Small Cell Lung Cancer are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RecruitingPhase 1
- Georgetown University Medical Center, Washington D.C.
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
- Site 1001, Washington D.C.
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
RecruitingPhase 3
- Maryland Oncology Hematology, Silver Spring · 7 mi away
- American Oncology Partners, PA - The Center for Cancer and Blood Disorders, Bethesda · 7 mi away
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RecruitingPhase 1/2
- Avenzo Therapeutics Recruiting Site, Washington D.C.
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
RecruitingPhase 2
- Georgetown Lombardi Cancer Center, Washington D.C.
Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- National Institutes of Health, Bethesda · 7 mi away
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecruitingPhase 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
Small Cell Lung Cancer trials in other cities
- Houston, TX26 studies
- Arlington, VA23 studies
- New York City, NY22 studies
- Boston, MA21 studies
- Los Angeles, CA20 studies
- Nashville, TN20 studies
- Orlando, FL15 studies
- Dallas, TX13 studies
- Cleveland, OH13 studies
- Chicago, IL13 studies
- St. Louis, MO13 studies
- Detroit, MI12 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.